Trial Profile
Multicentre, randomised, double-blind, placebo controlled trial on topically applied benvitimod cream in patients with psoriasis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Tapinarof (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 21 May 2012 Actual end date changed from 1 May 2011 to 31 Jul 2011 as reported by Chinese Clinical Trial Register.
- 29 Jun 2011 New trial record